Journal of Molecular Histology

, Volume 40, Issue 5–6, pp 379–385 | Cite as

Protective effects of the volatile oil of Nigella sativa seeds on β-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study

  • Mehmet Kanter
  • Meryem Akpolat
  • Cevat Aktas
Original Paper


The aim of this study was to evaluate the possible protective effects of the volatile oil of Nigella sativa (NS) seeds on insulin immunoreactivity and ultrastructural changes of pancreatic β-cells in STZ-induced diabetic rats. STZ was injected intraperitoneally at a single dose of 50 mg/kg to induce diabetes. The rats in NS treated groups were given NS (0.2 ml/kg) once a day orally for 4 weeks starting 3 days prior to STZ injection. To date, no ultrastructural changes of pancreatic β-cells in STZ induced diabetic rats by NS treatment have been reported. Islet cell degeneration and weak insulin immunohistochemical staining was observed in rats with STZ-induced diabetes. Increased intensity of staining for insulin, and preservation of β-cell numbers were apparent in the NS-treated diabetic rats. The protective effect of NS on STZ-diabetic rats was evident by a moderate increase in the lowered secretory vesicles with granules and also slight destruction with loss of cristae within the mitochondria of β-cell when compared to control rats. These findings suggest that NS treatment exerts a therapeutic protective effect in diabetes by decreasing morphological changes and preserving pancreatic β-cell integrity. Consequently, NS may be clinically useful for protecting β-cells against oxidative stress.


Nigella sativa Immunoreactivity Ultrastructure β-cell Experimental diabetes 



This study was supported as Project 855 by Trakya University Research Center, Edirne, Turkey.


  1. Aughsteen AA (2000) An ultrastructural study on the effect of streptozotocin on the islets of Langerhans in mice. J Electron Microsc 49681–49690Google Scholar
  2. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412CrossRefPubMedGoogle Scholar
  3. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH (1994) Cerebral function in diabetes mellitus. Diabetologia 37:643–650CrossRefPubMedGoogle Scholar
  4. Bolkent S, Yanardag R, Tabakoglu OA, Ozsoy SO (2000) Effects of chard (Beta vulgaris L.var. cicla) extract on pancreatic B cells in streptozotocin-diabetic rats: a morphological and biochemical study. J Ethnopharmacol 73:251–259CrossRefPubMedGoogle Scholar
  5. Bresnick GH (1986) Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol 104:989–990PubMedGoogle Scholar
  6. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Wagner Stingl L, EF Kolb H (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5:314–319CrossRefPubMedGoogle Scholar
  7. Chen YT, Zheng RL, Jia ZJ, Ju Y (1990) Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 9:19–20CrossRefPubMedGoogle Scholar
  8. Das AV, Padayatti PS, Paulose CS (1996) Effect of extract of Aegle marmelose (L.) Correa ex Roxb. On histological and ultrastructural changes in tissues of streptozotocin induced dibetic rats. Indian J Exp Biol 34:341–345PubMedGoogle Scholar
  9. Degirmenci I, Kalender S, Ustuner MC, Kalender Y, Gunes HV, Unal N, Basaran A (2002) The effects of acarbose and Rumex patientia on liver ultrastructure in streptozotocin induced diabetic (Type II) rats. Drugs Exp Clin Res 28(6):18229–18234Google Scholar
  10. Degirmenci I, Ustuner MC, Kalender Y, Kalender S, Gunes HV (2005) The effects of acarbose and Rumex patientia L. on ultrastructural and biochemical changes of pancreatic B cells in streptozotocin-induced diabetic rats. J Ethnopharmacol 97:555–559CrossRefPubMedGoogle Scholar
  11. El-Kadi A, Kandil O (1987) The black seed (Nigella sativa) and immunity: its effect on human T cell subset. Fed Proc 46:1222Google Scholar
  12. El-Tahir KE, Ashour MM, Al-Harbi MM (1993) The respiratory effects of the volatile oil of the black seed (Nigella sativa) in guinea-pigs: elucidation of the mechanism(s) of action. Gen Pharmacol 24:1115–1122PubMedGoogle Scholar
  13. Fararh KM, Atoji Y, Shimizu Y, Takewaki T (2002) Isulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster. Res Vet Sci 73:279–282CrossRefPubMedGoogle Scholar
  14. Gispen WH, Biessels GJ (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23:542–549CrossRefPubMedGoogle Scholar
  15. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller MM (1995) Enhanced serum levels of thiobarbituric acid reactive substances in diabetes mellitus. Am J Med 98:469–475CrossRefPubMedGoogle Scholar
  16. Hanafy MSM, Hatem ME (1991) Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J Ethnopharmacol 34:275–278CrossRefPubMedGoogle Scholar
  17. Hess ME, Haugaard WM, Torbati A (1986) Metabolic effects of acarbose in normal and diabetic rats, long- and short-term administration. Arch Int Pharmacodyn Ther 283163–283176Google Scholar
  18. Hong EG, Noh HL, Lee SK, Chung YS, Lee KW, Kim HM (2002) Insulin and glukagon secretions, and morphological change of pancreatic islets in OLETF rats, a model of type 2 diabetes mellitus. J Korean Med Sci 17:34–40PubMedGoogle Scholar
  19. Hsu SM, Raine L, Fanger H (1981) Use of avidinbiotin-peroxidase complex (ABC) in immunperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580PubMedGoogle Scholar
  20. Kanter M, Meral I, Yener Z, Ozbek H, Demir H (2003) Partial regeneration/proliferation of the β-Cells in the islets of Langerhans by Nigella sativa L in streptozocin-induced diabetic rats. Tohoku J Exp Med 20:213–219CrossRefGoogle Scholar
  21. Kanter M, Coskun O, Korkmaz A, Oter S (2004) Effects of Nigella sativa on oxidative stress and β-Cell damage in streptozocin-induced diabetic rats. Anat Rec 279:685–691CrossRefGoogle Scholar
  22. Kanter M, Coskun O, Budancamanak M (2005a) Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol 11(42):6684–6688PubMedGoogle Scholar
  23. Kanter M, Demir H, Karakaya C, Ozbek H (2005b) Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol 11(42):6662–6666PubMedGoogle Scholar
  24. Kanter M, Coskun O, Uysal H (2006a) The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol 80(4):217–224CrossRefPubMedGoogle Scholar
  25. Kanter M, Coskun O, Kalayci M, Buyukbas S, Cagavi F (2006b) Neuroprotective effects of Nigella sativa on experimental spinal cord injury in rats. Hum Exp Toxicol 25(3):127–133CrossRefPubMedGoogle Scholar
  26. Kröncke KD, Fehsel K, Sommer A, Rodriguez ML, Kolb-Bachofen V (1995) Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-nitroso-urea: streptozotocin contributes to islet cell DNA damage. Biol Chem Hoppe-Seyler 376:179–185PubMedGoogle Scholar
  27. Lown JW, Mclaughlin LW, Chang Y (1978) Mechanisms of action of 2-haloethyl-nitrosureas on DNA and its relation to their antileukemic properties. Bioorg Chem 7:97–110CrossRefGoogle Scholar
  28. Masutani M, Suzuki H, Kamada N, Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T (1999) Poly (ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin- induced diabetes. Proc Natl Acad Sci USA 96:2301–2304CrossRefPubMedGoogle Scholar
  29. Matkovics B, Kotorman M, Varga IS, Hai DQ, Varga C (1998) Oxidative stress in experimental diabetes induced by streptozotocin Acta Physiol Hung 85:29–38Google Scholar
  30. Mccall AL (1992) The impact of diabetes on the CNS. Diabetes 41557–41570Google Scholar
  31. Merzouk H, Madani S, Chabane D, Prost J, Bouchenak M, Belleville J (2000) Time- course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes. Clin Sci 98:21–30CrossRefPubMedGoogle Scholar
  32. Murata M, Takahashi A, Saito I, Kawanishi S (1999) Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol 57:881–887CrossRefPubMedGoogle Scholar
  33. Papaccio G, Linn T, Federlin K, Volkman A, Esposito V, Mezzogiorno V (1991) Further morphological and biochemical observations on early low dose streptozotocin diabetes in mice. Pancreas 6:659–667CrossRefPubMedGoogle Scholar
  34. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S (1999) Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin induced diabetes. Proc Natl Acad Sci USA 96:3059–3064CrossRefPubMedGoogle Scholar
  35. Rakieten NML, Nadkarni MV (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91–98Google Scholar
  36. Sandler S, Andersson A (1982) The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin induced diabetes in the mouse in vivo and in vitro. Diabetologia 23:374–378CrossRefPubMedGoogle Scholar
  37. Schein PS, Cooney DA, Vernon ML (1967) The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Cancer Res 27:2324–2332PubMedGoogle Scholar
  38. Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulinproducing cells. Diabetes 46:1733–1742CrossRefPubMedGoogle Scholar
  39. Uchigata Y, Yamamoto H, Kawamura A, Okamoto H (1982) Protection by superoxide dismutase, catalase and poly (ADP-ribose) sunthetase inhibitors against alloxan-and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem 257:6084–6088PubMedGoogle Scholar
  40. Weiss RB (1982) Streptozotocin: a review of it pharmacology, efficacy and toxicity. Cancer Treat Rep 66:427–438PubMedGoogle Scholar
  41. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMedGoogle Scholar
  42. Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294:284–286CrossRefPubMedGoogle Scholar
  43. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M (2000) Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie 55:379–382PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of Histology and Embryology, Faculty of MedicineTrakya UniversityEdirneTurkey

Personalised recommendations